|
|
Evaluation of the Impact of the Presence of Neutralizing L-Asparaginase Antibodies on the Efficacy and Safety of Graspa in Phase 3 Randomized Trial Versus Native L-Asparaginase in Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01518517)
Yves Bertrand
,
André Baruchel
,
Xavier Thomas
,
Nicolas Blin
,
Emmanuelle Tavernier
et al.
Blood, 2015, 126 (23), pp.3734
Journal articles
hal-01290438v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Abstract CT113: A phase III, multicenter, randomized study evaluating the efficacy and safety and efficacy of erythrocyte encapsulated l-asparaginase (Ery001) versus native l-asparaginase (L-asp) in combination with COOPRALL regimen in patients with first relapse of acut
Yves Bertrand
,
André Baruchel
,
Xavier Thomas
,
Nicolas Blin
,
Emmanuelle Tavernier
et al.
Journal articles
hal-01300807v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Is Arsenic Trioxide (ATO) Required in the Treatment of Standard Risk Newly Diagnosed APL? Analysis of a Randomized Trial (APL 2006) By the French Belgian Swiss APL Group
Lionel Adès
,
Xavier Thomas
,
Agnes Cuerci-Bres
,
Raffoux Emmanuel
,
Olivier Spertini
et al.
Blood, 2015, 126 (23), pp.451
Journal articles
hal-01300812v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
Francine Garnache-Ottou
,
Chrystelle Vidal
,
Sabeha Biichlé
,
Florian Renosi
,
Eve Poret
et al.
Journal articles
hal-02442440v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study.
Raouf Ben Abdelali
,
Vahid Asnafi
,
Thibaut Leguay
,
Nicolas Boissel
,
Agnès Buzyn
et al.
Journal articles
hal-00777203v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial
Anne Bouvier
,
Jean-Francois Hamel
,
Jacques Delaunay
,
Eric Delabesse
,
Pierre-Yves Dumas
et al.
Journal articles
hal-03604930v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Updated Clinical Activity of Graspa Versus Native l-Asparaginase in Combination with Cooprall Regimen in Phase 3 Randomized Trial in Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01518517)
André Baruchel
,
Yves Bertrand
,
Xavier Thomas
,
Nicolas Blin
,
Emmanuelle Tavernier
et al.
Blood, 2015, 126 (23), pp.3723
Journal articles
hal-01290425v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Pharmacokinetic and Pharmacodynamic Characterization of Graspa Versus Native L-Asparaginase in Combination with Cooprall Chemotherapy in a Phase 3 Randomized Trial for the Treatment of Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01 51851 7)
Xavier Thomas
,
Yves Bertrand
,
André Baruchel
,
Nicolas Blin
,
Emmanuelle Tavernier
et al.
Blood, 2015, 126 (23), pp.2492
Journal articles
hal-01290427v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Impact of body-surface area on patients' outcome in younger adults with acute myeloid leukemia
Xavier Cahu
,
Martin Carré
,
Christian Recher
,
Arnaud Pigneux
,
Mathilde Hunault-Berger
et al.
Journal articles
hal-01558818v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study
Laetitia Largeaud
,
Pascale Cornillet-Lefebvre
,
Jean-François Hamel
,
Pierre-Yves Dumas
,
Naïs Prade
et al.
Journal articles
hal-03623649v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Addition of Lomustine (CCNU) to Induction and Post-Remission Chemotherapy for Fit Elderly AML Patients without Unfavorable Cytogenetics: Results of the Lamsa-2007 Goelams Trial
Arnaud Pigneux
,
Christian Récher
,
Marie C. Bene
,
Julien Asselineau
,
Ariane C. Mineur
et al.
Blood, 2015, 126 (23)
Journal articles
hal-01295674v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|